161 filings
Page 5 of 9
8-K
m5tw7 7su5pecm
14 Jul 20
Helius Medical Technologies, Announces the Dismissal of the Shareholder Class Action Lawsuit
7:11am
8-K/A
unwcbo5c98y n2eer
2 Jul 20
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
1dd oersbmz0kmz
12 Jun 20
Submission of Matters to a Vote of Security Holders
7:47am
8-K
i2fu2aizcoqo5e3d
12 May 20
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS
10:58am
8-K
mavq5mld3v 07i
7 May 20
Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial
12:00am
8-K
ityrp08t jf6dry9izy
30 Apr 20
Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial(TBI-001) in TBI
8:24am
8-K
om1fmahwctue
22 Apr 20
Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors
7:08am
8-K
ud8g3wgpc5
16 Apr 20
Entry into a Material Definitive Agreement
7:03am
8-K
hazzdefg iys
27 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:14pm
8-K
0lm2jged
24 Mar 20
Regulation FD Disclosure
7:05am
8-K
ruak m1ff3
18 Mar 20
Helius Medical Technologies Announces $2.2 Million Registered Direct Offering
4:49pm
8-K
n21940keg3pl
12 Mar 20
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook
4:05pm
8-K
r4u8gl1
2 Mar 20
Results of Operations and Financial Condition
7:15am
8-K
841rr28 1k
19 Feb 20
Departure of Directors or Certain Officers
4:59pm
8-K
v97zli5
27 Jan 20
Entry into a Material Definitive Agreement
4:38pm
8-K
8nmkw
16 Dec 19
Departure of Directors or Certain Officers
4:17pm
8-K
da0c3e0qobgp52tss ur
25 Nov 19
Helius Medical Technologies, Inc. Announces Proposed Public Offering
5:17pm
8-K
ywuo4u
21 Nov 19
Other Events
9:56pm
8-K
x0ce7ucllpxs8 7vx
12 Nov 19
Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook
7:05am
8-K
wsrgowdl22aeat
24 Oct 19
Helius Medical Technologies, Inc. Announces Update on US Regulatory Strategy Following Pre-Submission Meeting with FDA
7:05am